P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
基本信息
- 批准号:8404007
- 负责人:
- 金额:$ 37.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:ADP Ribose TransferasesAcuteAddressAnimal ModelBacteriaBlindnessCellsComplementContact LensesCorneaCorneal DiseasesCorneal StromaDataDevelopmentDiseaseDisease ProgressionDoseEnzymesEpithelial CellsExtended-Wear Contact LensesEye InfectionsEye InjuriesGenomeGrantImmuneImmune responseImmune systemIndividualInfectionInfection preventionInvadedKeratitisLeadLeftLinkLungMediatingModelingMolecularMusNeutrophil InfiltrationOrganismPathogenesisPatientsPeptide HydrolasesPhenotypePhospholipasePilumPositioning AttributeProductionProperdinProteinsPseudomonas aeruginosaReportingResearchRoleSeverity of illnessShapesSignal TransductionSiteStagingSyringesTLR4 geneTLR5 geneToll-like receptorsType III Secretion System PathwayVirulenceVirulence FactorsVisual impairmentbacterial geneticschemokinecombatcorneal epitheliumcytotoxicdesignextracellularin vivokillingsmacrophagemicrobialneutrophilpreventresearch studyrhouptake
项目摘要
P. aeruginosa infections are a common cause of corneal disease associated with extended-wear
contact lens use here in the US. One of the primary virulence factors P. aeruginosa uses to promote disease is
its type III secretion system, a molecular syringe that allows the bacterium to directly inject effector proteins
into targeted host cells. The role of type III secretion in corneal disease has not been studied extensively, but
initial reports suggest that corneal disease depends on the complement of effectors being expressed by the
infecting bacteria. "Cytotoxic" strains expressing the potent phospholipase ExoU rely extensively on type III
secretion to promote disease, whereas ExoS-producing "invasive" strains, appear to not rely on type III
secretion in order to elicit corneal disease.
We have revisited the role of type III secretion in the pathogenesis of corneal disease elicited by ExoS+
"invasive" isolates of P. aeruginosa. Our preliminary data demonstrates that corneal disease relies critically on
type III secretion and on the two effectors ExoS and ExoT, in particular. In addition, we provide evidence that
the primary role of type III secretion in corneal disease is to stave off killing by infiltrating neutrophils.
Accordingly, the focus of this proposal is to determine the role of the individual enzymatic activities of ExoS
and ExoT in preventing clearance by neutrophils in vivo. We will correlate these findings with experiments
aimed at examining the role of ExoS and ExoT in preventing phagocytic killing by isolated primary neutrophils.
We will also examine the difference in pathogenesis between ExoU-expressing "cytotoxic" and ExoS-
expressing "invasive" strains of P. aeruginosa in order to determine if any differences can be directly linked to
the activities of these two effectors.
Understanding the role of effector proteins in corneal disease is an important step towards formulating
new strategies for preventing and treating P. aeruginosa infections of the eye.
铜绿假单胞菌感染是与长期配戴相关的角膜疾病的常见原因
隐形透镜在美国使用。铜绿假单胞菌用于促进疾病的主要毒力因子之一是
它的III型分泌系统,一个允许细菌直接注射效应蛋白的分子注射器,
进入目标宿主细胞。III型分泌物在角膜疾病中的作用尚未得到广泛研究,但
最初的报道表明,角膜疾病依赖于角膜上皮细胞表达的效应子的补体,
感染细菌表达强效磷脂酶ExoU的“细胞毒性”菌株广泛依赖于III型
分泌促进疾病,而产生ExoS的“侵入性”菌株,似乎不依赖于III型
分泌物以引起角膜疾病。
我们重新审视了III型分泌物在ExoS+引起的角膜疾病发病机制中的作用,
铜绿假单胞菌的“侵入性”分离株。我们的初步数据表明,角膜疾病严重依赖于
III型分泌和两个效应ExoS和ExoT,特别是。此外,我们提供的证据表明,
III型分泌物在角膜疾病中的主要作用是避免浸润中性粒细胞的杀伤。
因此,本提案的重点是确定ExoS的单个酶活性的作用
和ExoT在体内防止中性粒细胞清除中的作用。我们将把这些发现与实验联系起来
目的是检查ExoS和ExoT在防止分离的原代嗜中性粒细胞的吞噬杀伤中的作用。
我们还将研究表达ExoU的“细胞毒性”和表达ExoS的“细胞毒性”之间的发病机制的差异。
表达铜绿假单胞菌的“侵入性”菌株,以确定是否有任何差异可以直接与
这两个效应器的活动。
了解效应蛋白在角膜疾病中的作用是制定角膜疾病治疗方案的重要一步。
预防和治疗眼部铜绿假单胞菌感染的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arne Rietsch其他文献
Arne Rietsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arne Rietsch', 18)}}的其他基金
Host cell factors controlling type III secretion effector translocation
控制III型分泌效应器易位的宿主细胞因子
- 批准号:
10416972 - 财政年份:2022
- 资助金额:
$ 37.29万 - 项目类别:
Host cell factors controlling type III secretion effector translocation
控制III型分泌效应器易位的宿主细胞因子
- 批准号:
10586145 - 财政年份:2022
- 资助金额:
$ 37.29万 - 项目类别:
Development of recombinase-based tools to study established infections
开发基于重组酶的工具来研究已确定的感染
- 批准号:
10201472 - 财政年份:2020
- 资助金额:
$ 37.29万 - 项目类别:
Development of recombinase-based tools to study established infections
开发基于重组酶的工具来研究已确定的感染
- 批准号:
10040615 - 财政年份:2020
- 资助金额:
$ 37.29万 - 项目类别:
Type III Secretion Translocon Structure and Function
III型分泌易位子的结构和功能
- 批准号:
8701601 - 财政年份:2014
- 资助金额:
$ 37.29万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8962457 - 财政年份:2012
- 资助金额:
$ 37.29万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8217524 - 财政年份:2012
- 资助金额:
$ 37.29万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8597435 - 财政年份:2012
- 资助金额:
$ 37.29万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
9115162 - 财政年份:2012
- 资助金额:
$ 37.29万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Standard Grant